Cargando…

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance

BACKGROUND—: Cardiac sarcoidosis is associated with an increased risk of heart failure and sudden death, but its risk in patients with preserved left ventricular ejection fraction is unknown. Using cardiovascular magnetic resonance in patients with extracardiac sarcoidosis and preserved left ventric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murtagh, Gillian, Laffin, Luke J., Beshai, John F., Maffessanti, Francesco, Bonham, Catherine A., Patel, Amit V., Yu, Zoe, Addetia, Karima, Mor-Avi, Victor, Moss, Joshua D., Hogarth, D. Kyle, Sweiss, Nadera J., Lang, Roberto M., Patel, Amit R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718184/ https://www.ncbi.nlm.nih.gov/pubmed/26763280 http://dx.doi.org/10.1161/CIRCIMAGING.115.003738

Ejemplares similares

Refining risk assessment in cardiac sarcoidosis: a role for burden of late gadolinium enhancement and right ventricular function
por: Murtagh, Gillian, et al.
Publicado: (2014)

Influence of late gadolinium enhancement on left ventricular morphology and function in patients with sarcoidosis
por: Patel, Amit R, et al.
Publicado: (2009)

Inter-technique agreement between two-dimensional echocardiography and cardiovascular magnetic resonance imaging in the setting of bicuspid aortic valve disease
por: Vicedo, Beatriz Miralles, et al.
Publicado: (2014)

Three-dimensional changes in regional right ventricular curvature and function in tetralogy of fallot
por: Cossor, Waseem, et al.
Publicado: (2015)

Editorial: Sarcoidosis—The great mimicker
por: Korsten, Peter, et al.
Publicado: (2022)

Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
por: Addetia, Karima, et al.
Publicado: (2016)

Quantification of the severity of tricuspid regurgitation from cardiac magnetic resonance cine images
por: Medvedofsky, Diego, et al.
Publicado: (2016)

Objective selection of short-axis slices for automated quantification of left ventricular size and function by cardiovascular magnetic resonance
por: Marino, Marco, et al.
Publicado: (2015)

Full-Thickness Eyelid Lesions in Sarcoidosis
por: Collins, Megan E., et al.
Publicado: (2013)

Treatment of COVID-19 in Patients With Sarcoidosis
por: Kondle, Shreya, et al.
Publicado: (2021)

COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
por: Manansala, Michael, et al.
Publicado: (2021)

Association of Neutrophil to Lymphocyte Ratio and Pulmonary Hypertension in Sarcoidosis Patients
por: Mirsaeidi, Mehdi, et al.
Publicado: (2016)

Alterations in regional right ventricular shape in patients following tetralogy of Fallot repair involving a transannular Patch
por: Singh, Amita, et al.
Publicado: (2016)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis
por: Hutt, Erika, et al.
Publicado: (2023)

Case Series: COVID-19 in African American Patients With Sarcoidosis
por: Manansala, Michael, et al.
Publicado: (2020)

Management of extrapulmonary sarcoidosis: challenges and solutions
por: Al-Kofahi, Khalid, et al.
Publicado: (2016)

Designing pulmonary arterial hypertension trials for detecting change in right ventricular function using cardiovascular magnetic resonance: what is the appropriate sample size?
por: Addetia, Karima, et al.
Publicado: (2013)

RV dyssynchrony in PAH as evidenced by slice to slice minimum volume timing
por: Han, Qiao, et al.
Publicado: (2015)

Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis
por: Aronov, Avi, et al.
Publicado: (2022)

Activity tracking devices in sarcoidosis
por: Klein, Rebecca A., et al.
Publicado: (2023)

Efzofitimod for the Treatment of Pulmonary Sarcoidosis
por: Culver, Daniel A., et al.
Publicado: (2023)

Gene Co-expression Networks Identifies Common Hub Genes Between Cutaneous Sarcoidosis and Discoid Lupus Erythematosus
por: Nickles, Melissa A., et al.
Publicado: (2020)

Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
por: Ascoli, Christian, et al.
Publicado: (2022)

Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy
por: Syed, Huzaefah, et al.
Publicado: (2020)

Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis
por: Zhou, Tong, et al.
Publicado: (2012)

Using all-cause mortality to define severe RV dilation with RV/LV volume ratio
por: Altmayer, Stephan P. L., et al.
Publicado: (2018)

Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)

CMR RV size assessment should include RV to LV volume ratio
por: Altmayer, Stephan P, et al.
Publicado: (2015)

Cardiac Sarcoidosis: A Picture May Be Worth a Thousand Words, But Do We Need More?
por: Patel, Amit R., et al.
Publicado: (2019)

Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study
por: Rahaghi, Franck F., et al.
Publicado: (2020)

Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry
por: Sweiss, Nadera J., et al.
Publicado: (2011)

Semi-quantitative assessment of resting perfusion in chronic myocardial infarction
por: Patel, Mita, et al.
Publicado: (2015)

Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy
por: Liu, Jie, et al.
Publicado: (2022)

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study
por: Gatzoulis, Konstantinos A, et al.
Publicado: (2019)

Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire
por: Baughman, Robert P., et al.
Publicado: (2020)

Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: Results of a self-reporting questionnaire
por: Vagts, Christen, et al.
Publicado: (2023)

Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review
por: Sweis, Jaleel Jerry G., et al.
Publicado: (2022)

Editorial: Pulmonary sarcoidosis
por: Dhooria, Sahajal, et al.
Publicado: (2023)

Sarcoidosis in U.S. Military Veterans: Can Lessons from Those Who Have Served Shape the Future of Sarcoidosis?
por: Farah, Naima, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_77p4jejhj0psj1tluoldi9q6lh